CS227305B2 - Method of preparing heterocyclic oxypropanolamine derivatives - Google Patents

Method of preparing heterocyclic oxypropanolamine derivatives Download PDF

Info

Publication number
CS227305B2
CS227305B2 CS801055A CS105580A CS227305B2 CS 227305 B2 CS227305 B2 CS 227305B2 CS 801055 A CS801055 A CS 801055A CS 105580 A CS105580 A CS 105580A CS 227305 B2 CS227305 B2 CS 227305B2
Authority
CS
Czechoslovakia
Prior art keywords
group
alkyl
eine
oder
hydroxy
Prior art date
Application number
CS801055A
Other languages
Czech (cs)
English (en)
Inventor
Walter Gunar Dr Friebe
Helmut Michel
Carl H Dr Ross
Fritz Dr Wiedemann
Wolfgang Dr Bartsch
Karl Prof Dr Dietmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Priority to CS806604A priority Critical patent/CS227312B2/cs
Priority to CS806605A priority patent/CS227313B2/cs
Priority to CS814336A priority patent/CS227327B2/cs
Publication of CS227305B2 publication Critical patent/CS227305B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
CS801055A 1979-02-16 1980-02-15 Method of preparing heterocyclic oxypropanolamine derivatives CS227305B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CS806604A CS227312B2 (cs) 1979-02-16 1980-09-30 Způsob přípravy heterocyklických oxypropanolaminových derivátů
CS806605A CS227313B2 (cs) 1979-02-16 1980-09-30 Způsob přípravy heterocyklických oxypropanolaminových derivátů
CS814336A CS227327B2 (cs) 1979-02-16 1981-06-10 Způsob přípravy heterocyklických oxypropanolaminových derivátů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792905877 DE2905877A1 (de) 1979-02-16 1979-02-16 Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
CS227305B2 true CS227305B2 (en) 1984-04-16

Family

ID=6063044

Family Applications (1)

Application Number Title Priority Date Filing Date
CS801055A CS227305B2 (en) 1979-02-16 1980-02-15 Method of preparing heterocyclic oxypropanolamine derivatives

Country Status (17)

Country Link
US (1) US4346093A (en:Method)
EP (1) EP0014951B1 (en:Method)
JP (1) JPS55120559A (en:Method)
AT (1) ATE2190T1 (en:Method)
AU (1) AU531282B2 (en:Method)
CA (1) CA1134827A (en:Method)
CS (1) CS227305B2 (en:Method)
DD (1) DD148774A5 (en:Method)
DE (2) DE2905877A1 (en:Method)
DK (1) DK65380A (en:Method)
ES (1) ES488657A1 (en:Method)
FI (1) FI66371C (en:Method)
HK (1) HK4486A (en:Method)
HU (1) HU184719B (en:Method)
IL (1) IL59352A (en:Method)
SU (1) SU1243622A3 (en:Method)
ZA (1) ZA80894B (en:Method)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DK187980A (da) 1979-05-04 1980-11-05 Continental Pharma Fremgangsmaade til fremstilling af benzimidazolderivater
IE810250L (en) * 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
DE3030047A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3131146A1 (de) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2523964B1 (fr) * 1982-03-23 1985-09-27 Sanofi Sa Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation
DE3310891A1 (de) * 1983-03-25 1984-09-27 Boehringer Mannheim Gmbh, 6800 Mannheim Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
US4562200A (en) * 1983-06-30 1985-12-31 American Home Products Corporation 5(Indolyl) and 5(2,3-dihydroindolyl) substituted aminoethanols and their use as anti-hypertensives
JPH0720861B2 (ja) * 1984-04-09 1995-03-08 ザ デュポン マーク ファーマソウテイカル カンパニー 心臓障害の処置または予防用の医薬組成物および方法
DE3540149A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Verwendung von 1-(benztriazol-4-yloxy)3-(2-(2-methoxyphenoxy) -ethylamino)-2-propanol als antiglaukommittel, optisch aktive r und s isomere dieser substanz, verfahren zur herstellung derselben sowie arzneimittel, die diese substanzen enthalten
US5081121A (en) * 1988-05-24 1992-01-14 Tatsushi Osawa 4(1h)-quinolone derivatives
AU642041B2 (en) * 1990-09-13 1993-10-07 Beecham Group Plc Indole ureas as 5 HT receptor antagonist
EP0711284A1 (en) * 1993-07-31 1996-05-15 Smithkline Beecham Plc 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ES2171839T3 (es) * 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
FR2756286A1 (fr) * 1996-11-27 1998-05-29 Pf Medicament Amino alcools aromatiques, leur preparation et leurs applications comme medicaments
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
AU1580101A (en) 1999-11-15 2001-05-30 Eli Lilly And Company Indazolyloxy propanolamines for improving livestock production
TW593278B (en) * 2001-01-23 2004-06-21 Wyeth Corp 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
SE0102640D0 (sv) * 2001-07-31 2001-07-31 Astrazeneca Ab Novel compounds
KR20190017795A (ko) * 2016-05-13 2019-02-20 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 아드레날린 수용체 조절 화합물 및 이의 사용 방법
GB202213163D0 (en) * 2022-09-08 2022-10-26 Cambridge Entpr Ltd Novel compounds, compositions and therapeutic uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623749A (en:Method) 1961-12-08
CH483423A (de) * 1967-05-29 1969-12-31 Sandoz Ag Verfahren zur Herstellung einer neuen Indolverbindung
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
CH536839A (de) * 1970-03-24 1973-05-15 Sandoz Ag Verfahren zur Herstellung einer neuen Indolverbindung
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
SE379196B (en:Method) 1971-06-24 1975-09-29 Sandoz Ag
DE2508251C2 (de) 1975-02-26 1983-12-29 Boehringer Mannheim Gmbh, 6800 Mannheim Derivate des Indols, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
US4189494A (en) * 1975-11-06 1980-02-19 Sandoz Ltd. Reducing free fatty acid of the blood and suppressing appetite
CH624395A5 (en:Method) 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2619164C2 (de) 1976-04-30 1985-07-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indazolyl-(4)-oxy-propanolamine, Verfahren zu ihrer Herstellung und deren Verwendung
DE2626890A1 (de) 1976-06-16 1977-12-29 Boehringer Mannheim Gmbh Neue derivate des indols, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE2651574A1 (de) 1976-11-12 1978-05-18 Boehringer Mannheim Gmbh Ein neues aminopropanol-derivat und verfahren zu dessen herstellung
NZ187066A (en) * 1977-05-03 1981-02-11 Hoffmann La Roche 4-(3-substitutedamino-2-hydroxypropoxy)-benzimidazolidin-2-(ones or thiones)
US4235919A (en) * 1977-07-21 1980-11-25 Sandoz Ltd. 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical use thereof
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
DE2801980A1 (de) * 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0003758A1 (de) * 1978-02-09 1979-09-05 Ciba-Geigy Ag Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
SU1243622A3 (ru) 1986-07-07
DE2905877A1 (de) 1980-08-28
FI66371B (fi) 1984-06-29
US4346093A (en) 1982-08-24
EP0014951A2 (de) 1980-09-03
FI800408A7 (fi) 1980-08-17
ES488657A1 (es) 1980-09-16
JPS6348864B2 (en:Method) 1988-09-30
EP0014951B1 (de) 1983-01-12
IL59352A0 (en) 1980-05-30
ATE2190T1 (de) 1983-01-15
CA1134827A (en) 1982-11-02
DE3061555D1 (en) 1983-02-17
AU531282B2 (en) 1983-08-18
EP0014951A3 (en) 1981-02-04
FI66371C (fi) 1984-10-10
AU5541080A (en) 1980-08-21
HU184719B (en) 1984-10-29
DK65380A (da) 1980-08-17
JPS55120559A (en) 1980-09-17
DD148774A5 (de) 1981-06-10
IL59352A (en) 1985-01-31
ZA80894B (en) 1981-09-30
HK4486A (en) 1986-01-31

Similar Documents

Publication Publication Date Title
CS227305B2 (en) Method of preparing heterocyclic oxypropanolamine derivatives
EP0042592B1 (de) N-Heteroaryl-alkylendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung
EP0129128B1 (de) 2-Pyrimidinyl-l-piperazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0316723B1 (en) 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments
EP0006506B1 (de) 1,2-Dihydro-chinolin-2-on-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE3241102A1 (de) Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
EP0400661A1 (en) Agents for treatment of brain ischemia
EP0677042B1 (fr) Ligands selectifs des recepteurs 5ht1d-5ht1b derives d'indole-piperazine utiles comme medicaments
DE2461604A1 (de) 8-hydroxy-3,4-dihydrocarbostyril- derivate, verfahren zu ihrer herstellung und arzneimittel
CH641757A5 (en) O-Alkylated hydroxylamines and process for the preparation thereof
US4952598A (en) 3-phenyl indolinone derivatives, processes for their preparation, medicaments containing them, and their use
DE69324212T2 (de) Indol-7-carboxamide Derivate als Analgetika
FI57588B (fi) Foerfarande foer framstaellning av nya antiviralt verksamma cykliska karbamidderivat och salter daerav
DE3101502A1 (de) Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre hersttellung und diese enthaltendetherapeutische mittel
HU191599B (en) Process for producing bis/piperazinyl-,or homopiperazinyl/-alkanes
US2997472A (en) Certificate of correction
US2725379A (en) Triazeve pharmaceuticals
EP0152596A1 (de) Neue 1,3-Dioxolanylderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und diese Verbindungen enthaltendes Arzneimittel
JPS63145286A (ja) 二環性イミダゾ−ル誘導体
EP0071950B1 (de) Neue Heteroaryloxypropanolamine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5332743A (en) Benzyl and benzhydryl alcohols
CS214759B2 (en) Method of making the piperidin derivatives of esters of 4,5-diacyl-3-hydroxy-pyrrol-2-carboxyl acid
US3322768A (en) Aralkyl piperazines and salts thereof
US3433802A (en) 3-(n-lower-alkylanilino)pyrrolidines
JPS6130668B2 (en:Method)